In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
Sanfetrinem, formerly GV104326, is a new trinem antimicrobial agent with extensive in vitro activity for a variety of different bacteria. The activity of sanfetrinem was determined using a broth microdilution MIC method versus a large number of clinical isolates of Streptococcus pneumoniae, Haemophi...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1996
|
| _version_ | 1797101906679562240 |
|---|---|
| author | Doern, G Pierce, G Brueggemann, A |
| author_facet | Doern, G Pierce, G Brueggemann, A |
| author_sort | Doern, G |
| collection | OXFORD |
| description | Sanfetrinem, formerly GV104326, is a new trinem antimicrobial agent with extensive in vitro activity for a variety of different bacteria. The activity of sanfetrinem was determined using a broth microdilution MIC method versus a large number of clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis obtained in a recent 30-center United States surveillance study. The sanfetrinem MIC50 and MIC90 values for these three organism groups were 0.015 and 0.5 microgram/ml, 0.25, and 0.5 microgram/ml, and 0.015 and 0.03, respectively. |
| first_indexed | 2024-03-07T05:58:30Z |
| format | Journal article |
| id | oxford-uuid:eb5a0a68-517e-4b13-8798-4341a5661110 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:58:30Z |
| publishDate | 1996 |
| record_format | dspace |
| spelling | oxford-uuid:eb5a0a68-517e-4b13-8798-4341a56611102022-03-27T11:09:03ZIn vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:eb5a0a68-517e-4b13-8798-4341a5661110EnglishSymplectic Elements at Oxford1996Doern, GPierce, GBrueggemann, ASanfetrinem, formerly GV104326, is a new trinem antimicrobial agent with extensive in vitro activity for a variety of different bacteria. The activity of sanfetrinem was determined using a broth microdilution MIC method versus a large number of clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis obtained in a recent 30-center United States surveillance study. The sanfetrinem MIC50 and MIC90 values for these three organism groups were 0.015 and 0.5 microgram/ml, 0.25, and 0.5 microgram/ml, and 0.015 and 0.03, respectively. |
| spellingShingle | Doern, G Pierce, G Brueggemann, A In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. |
| title | In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. |
| title_full | In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. |
| title_fullStr | In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. |
| title_full_unstemmed | In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. |
| title_short | In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. |
| title_sort | in vitro activity of sanfetrinem gv104326 a new trinem antimicrobial agent versus streptococcus pneumoniae haemophilus influenzae and moraxella catarrhalis |
| work_keys_str_mv | AT doerng invitroactivityofsanfetrinemgv104326anewtrinemantimicrobialagentversusstreptococcuspneumoniaehaemophilusinfluenzaeandmoraxellacatarrhalis AT pierceg invitroactivityofsanfetrinemgv104326anewtrinemantimicrobialagentversusstreptococcuspneumoniaehaemophilusinfluenzaeandmoraxellacatarrhalis AT brueggemanna invitroactivityofsanfetrinemgv104326anewtrinemantimicrobialagentversusstreptococcuspneumoniaehaemophilusinfluenzaeandmoraxellacatarrhalis |